Opinion · 2 Dec 2025
EditorialPublished 2011
Efficient and Safe Intra-cellular Transport of Targeted Nanomedicines: are we there Yet?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Efficient transport of drugs into cells in the body is a key factor to achieve relevant therapeutic effects for most clinical applications. However, this aspect still represents a main obstacle for a considerable number of therapeutic agents, such as poorly soluble drugs, relatively large molecules, and many biological agents, which cannot gain access to the intra-cellular compartment per se. In such cases, coupling of therapeutic agents to molecules and/or supra-molecular carriers that display affinity toward biological surfaces in the body (a strategy known as drug targeting), holds promise to improve drug transport to those sites where the therapeutic action is required [1-3]. The development of strategies aimed to improving control of drug biodistribution at the cellular and/or sub-cellular level is, hence, a very active area of research. Affinity molecules can be chosen to favor adhesion to either broadly distributed or rather specific biological markers, depending on the degree of selectivity required for a particular clinical application. Drugs and/or their carriers can be targeted to distribution particular cellular receptors involved in endocytic transport or coupled to cell penetrating peptides, in order to achieve intracellular.
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nanomedicine & Biotherapeutic Discovery.
Review article · 20 Jun 2025
Metal Nanoparticles in Medicine: Biosynthesis and Applications in Chemotherapy, Drug Delivery, and Anticancer, Antibacterial and Antioxidant Chemical Production
Research article · 28 Apr 2025
A Novel Chemical Entity, that Reverses Warburg Metabolism by Disrupting VDAC1/HK2 Interaction through
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Biotherapeutic Discovery
- SubjectNanotechnology
- BylineArticles whose byline prints “Silvia Muro”
